Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

39.75
Delayed Data
As of Oct 20
 +0.10 / +0.25%
Today’s Change
7.50
Today|||52-Week Range
41.80
+227.16%
Year-to-Date
No recent news for Zogenix Inc.

Today’s Trading

Previous close39.65
Today’s open39.55
Day’s range39.25 - 40.60
Volume1,167,516
Average volume (3 months)1,128,169
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-22.42%
Earnings growth (this year)-34.72%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+4.22%
P/E ratioNM
Price/Sales10.44
Price/Book8.17

Competitors

 Today’s
change
Today’s
% change
CORICorium International...+0.19+1.89%
COLLCollegium Pharmaceut...-0.04-0.34%
IDRAIdera Pharmaceutical...-0.03-1.26%
CRVSCorvus Pharmaceutica...-0.62-4.03%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.96
Annual revenue (last year)$28.9M
Annual profit (last year)-$69.7M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Stephen J. Farr
CFO, Secretary, Treasurer &
Executive VP
Michael P. Smith
Corporate headquarters
Emeryville, California

Forecasts